Takeda Pharmaceuticals International Co
Dr. Bin Li leads a computational biology team at the Data Science Institute, Takeda Pharmaceuticals. His team provides computational supports on translational medicine research for various Takeda compounds. They develop computational methods for clinical biomarker research, build predictive models for patient stratification and disease indication selection, as well as design/implement translational data repositories. His team is also responsible for method evaluation and pipeline building for various NGS platforms, including WES, RNA-seq, and targeted NGS panels.
Translational research on various Takeda compounds.